1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 0000-0002-0450-8907 Liu, G. 0000-0001-6781-367X Ishida, Y. 0000-0001-9342-2525 Swapna, G.V.T. Kleinfelter, S. 0000-0002-5792-8112 Koepnick, B. 0000-0001-7896-6217 Baker, D. 0000-0002-9440-3059 Montelione, G.T. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Nature NATUAS 0006 1476-4687 570 390 394 10.1038/s41586-019-1274-4 31168091 De novo protein design by citizen scientists. 2019 10.2210/pdb6msp/pdb pdb_00006msp 11725.060 De novo Designed Protein Foldit3 1 man polymer no no MGHHHHHHENLYFQSHMTDELLERLRQLFEELHERGTEIVVEVHINGERDEIRVRNISKEELKKLLERIREKIEREGSSE VEVNVHSGGQTWTFNEK MGHHHHHHENLYFQSHMTDELLERLRQLFEELHERGTEIVVEVHINGERDEIRVRNISKEELKKLLERIREKIEREGSSE VEVNVHSGGQTWTFNEK A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n sample 1 97 32630 synthetic construct 83333 Escherichia coli K-12 Biological sequence citation citation_author citation database_2 pdbx_database_status repository Initial release Data collection Database references Data collection Database references Database references Other 1 0 2019-06-12 1 1 2019-06-19 1 2 2019-07-03 1 3 2023-06-14 _citation.country _citation.journal_abbrev _citation.journal_id_ASTM _citation.journal_id_CSD _citation.journal_id_ISSN _citation.pdbx_database_id_PubMed _citation.title _citation.year _citation.journal_volume _citation.page_first _citation.page_last _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data De novo Designed Protein Foldit3 N RCSB Y RCSB 2018-10-17 REL REL REL REL target function 100 20 isotropic 1 3D 1H-13C NOESY isotropic 1 3D 1H-15N NOESY isotropic 1 3D HNCACB isotropic 1 3D CBCA(CO)NH isotropic 1 3D HNCO isotropic 1 3D HCCH-TOCSY isotropic 1 2D 1H-15N HSQC isotropic 1 2D 1H-13C HSQC 0.3 mM [U-13C; U-15N] 0.2 mM condition_1 6.5 pH 1 atm 298 K molecular dynamics 1 medoid 0.3 mM [U-13C; U-15N] foldit3, 90% H2O/10% D2O The purified protein was dialyzed against 20 mM potassium phosphate (pH 6.5) and the protein concentration was adjusted to between 0.3-0.4 mM for NMR studies. 15N13C 90% H2O/10% D2O solution Brunger, Adams, Clore, Gros, Nilges and Read refinement CNS Huang, Tejero, Powers and Montelione refinement AutoStructure Guntert, Mumenthaler and Wuthrich structure calculation CYANA Zimmerman, Moseley, Kulikowski and Montelione chemical shift assignment AutoAssign Goddard peak picking Sparky Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax processing NMRPipe Bruker Biospin collection TopSpin 600 Bruker AVANCE III MET 1 n 1 MET 1 A GLY 2 n 2 GLY 2 A HIS 3 n 3 HIS 3 A HIS 4 n 4 HIS 4 A HIS 5 n 5 HIS 5 A HIS 6 n 6 HIS 6 A HIS 7 n 7 HIS 7 A HIS 8 n 8 HIS 8 A GLU 9 n 9 GLU 9 A ASN 10 n 10 ASN 10 A LEU 11 n 11 LEU 11 A TYR 12 n 12 TYR 12 A PHE 13 n 13 PHE 13 A GLN 14 n 14 GLN 14 A SER 15 n 15 SER 15 A HIS 16 n 16 HIS 16 A MET 17 n 17 MET 17 A THR 18 n 18 THR 18 A ASP 19 n 19 ASP 19 A GLU 20 n 20 GLU 20 A LEU 21 n 21 LEU 21 A LEU 22 n 22 LEU 22 A GLU 23 n 23 GLU 23 A ARG 24 n 24 ARG 24 A LEU 25 n 25 LEU 25 A ARG 26 n 26 ARG 26 A GLN 27 n 27 GLN 27 A LEU 28 n 28 LEU 28 A PHE 29 n 29 PHE 29 A GLU 30 n 30 GLU 30 A GLU 31 n 31 GLU 31 A LEU 32 n 32 LEU 32 A HIS 33 n 33 HIS 33 A GLU 34 n 34 GLU 34 A ARG 35 n 35 ARG 35 A GLY 36 n 36 GLY 36 A THR 37 n 37 THR 37 A GLU 38 n 38 GLU 38 A ILE 39 n 39 ILE 39 A VAL 40 n 40 VAL 40 A VAL 41 n 41 VAL 41 A GLU 42 n 42 GLU 42 A VAL 43 n 43 VAL 43 A HIS 44 n 44 HIS 44 A ILE 45 n 45 ILE 45 A ASN 46 n 46 ASN 46 A GLY 47 n 47 GLY 47 A GLU 48 n 48 GLU 48 A ARG 49 n 49 ARG 49 A ASP 50 n 50 ASP 50 A GLU 51 n 51 GLU 51 A ILE 52 n 52 ILE 52 A ARG 53 n 53 ARG 53 A VAL 54 n 54 VAL 54 A ARG 55 n 55 ARG 55 A ASN 56 n 56 ASN 56 A ILE 57 n 57 ILE 57 A SER 58 n 58 SER 58 A LYS 59 n 59 LYS 59 A GLU 60 n 60 GLU 60 A GLU 61 n 61 GLU 61 A LEU 62 n 62 LEU 62 A LYS 63 n 63 LYS 63 A LYS 64 n 64 LYS 64 A LEU 65 n 65 LEU 65 A LEU 66 n 66 LEU 66 A GLU 67 n 67 GLU 67 A ARG 68 n 68 ARG 68 A ILE 69 n 69 ILE 69 A ARG 70 n 70 ARG 70 A GLU 71 n 71 GLU 71 A LYS 72 n 72 LYS 72 A ILE 73 n 73 ILE 73 A GLU 74 n 74 GLU 74 A ARG 75 n 75 ARG 75 A GLU 76 n 76 GLU 76 A GLY 77 n 77 GLY 77 A SER 78 n 78 SER 78 A SER 79 n 79 SER 79 A GLU 80 n 80 GLU 80 A VAL 81 n 81 VAL 81 A GLU 82 n 82 GLU 82 A VAL 83 n 83 VAL 83 A ASN 84 n 84 ASN 84 A VAL 85 n 85 VAL 85 A HIS 86 n 86 HIS 86 A SER 87 n 87 SER 87 A GLY 88 n 88 GLY 88 A GLY 89 n 89 GLY 89 A GLN 90 n 90 GLN 90 A THR 91 n 91 THR 91 A TRP 92 n 92 TRP 92 A THR 93 n 93 THR 93 A PHE 94 n 94 PHE 94 A ASN 95 n 95 ASN 95 A GLU 96 n 96 GLU 96 A LYS 97 n 97 LYS 97 A author_defined_assembly 1 monomeric gel filtration 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A O GLU 48 A O GLU 48 A N ILE 45 A N ILE 45 A N GLU 42 A N GLU 42 A O ASN 84 A O ASN 84 A N VAL 83 A N VAL 83 A O PHE 94 A O PHE 94 1 A HIS 3 -169.65 116.05 1 A MET 17 -169.33 -53.02 1 A ASP 19 -58.79 93.04 1 A GLU 20 -145.85 -64.63 1 A THR 37 -77.49 -169.92 1 A GLU 38 -63.24 88.60 1 A ASN 46 71.68 -72.05 1 A ASN 56 63.40 73.76 2 A HIS 5 -165.68 112.63 2 A HIS 8 -152.00 58.84 2 A HIS 16 -145.45 -27.26 2 A MET 17 -91.95 55.41 2 A THR 18 44.61 27.67 2 A GLU 38 -57.78 100.74 2 A ASN 56 56.15 83.65 3 A HIS 4 -59.07 88.28 3 A THR 18 70.98 -5.05 3 A ASN 46 63.86 -71.93 3 A ASN 56 58.79 82.85 3 A GLU 80 -148.58 29.56 4 A HIS 4 -69.15 97.84 4 A HIS 6 50.11 13.62 4 A LEU 11 -63.74 76.85 4 A SER 15 -66.49 86.81 4 A ARG 55 -122.19 -58.03 4 A GLU 80 -162.20 94.95 5 A HIS 8 -68.73 86.92 5 A GLU 38 -58.59 86.54 5 A ARG 55 -121.90 -85.33 6 A HIS 4 -157.26 76.51 6 A HIS 6 -161.66 79.07 6 A HIS 7 -65.35 84.91 6 A TYR 12 -126.22 -160.71 6 A SER 15 57.69 71.80 6 A GLU 20 -153.24 -57.16 6 A GLU 38 -63.50 97.29 6 A ASN 56 59.20 80.24 6 A GLU 80 -84.61 41.42 7 A HIS 4 -167.94 98.10 7 A HIS 16 -133.26 -70.79 7 A MET 17 -174.22 -179.24 7 A THR 18 -143.22 31.37 7 A GLU 20 -165.96 -57.49 7 A ASN 56 66.70 88.52 8 A ASN 56 51.89 77.26 8 A GLU 76 -86.95 -75.94 9 A GLU 38 -65.11 98.21 9 A ASN 46 63.95 -74.52 9 A ARG 55 -115.76 -92.15 9 A ASN 56 -97.20 46.36 9 A SER 87 -161.44 105.46 10 A ARG 55 -105.95 -67.57 10 A SER 87 -161.06 108.95 11 A THR 18 -63.91 97.18 11 A ARG 55 -127.62 -85.75 11 A GLU 80 -153.53 85.39 12 A PHE 13 -96.04 46.14 12 A MET 17 62.57 90.38 12 A ASP 19 75.65 -65.71 12 A THR 37 50.47 171.12 12 A ASN 56 61.18 87.76 13 A HIS 8 67.31 110.95 13 A PHE 13 -100.81 -80.10 13 A GLN 14 69.49 -30.17 13 A ARG 55 -121.02 -77.60 13 A ASN 56 -98.46 41.23 13 A GLU 96 -57.69 103.43 14 A HIS 5 -135.71 -64.10 14 A GLU 20 80.38 -49.36 14 A ASN 46 72.05 -71.43 14 A ARG 55 -126.43 -83.12 15 A HIS 6 -68.76 98.52 15 A HIS 7 -62.16 96.23 15 A GLU 9 61.41 -72.43 15 A SER 15 -64.11 96.50 15 A THR 18 68.10 -69.24 15 A ASN 46 67.79 -63.05 15 A GLU 80 -63.93 86.82 16 A HIS 7 -65.40 89.72 16 A HIS 8 -69.92 -101.94 16 A GLU 9 69.43 -25.33 16 A LEU 11 76.02 -23.77 16 A TYR 12 -72.88 -168.62 16 A ASP 19 -159.90 -33.57 16 A GLU 38 -65.15 86.56 16 A ARG 55 -117.98 -80.25 16 A ASN 56 -104.59 57.82 17 A HIS 6 -69.69 80.52 17 A HIS 7 -176.62 149.54 17 A TYR 12 -123.10 -76.48 17 A GLU 20 72.65 -11.23 17 A GLU 38 -63.22 93.20 17 A ARG 55 -123.97 -89.15 17 A ASN 56 -92.99 37.73 17 A SER 87 -161.30 101.84 19 A HIS 3 -163.39 107.35 19 A HIS 6 59.99 86.34 19 A HIS 8 -149.13 54.92 19 A ASN 10 -150.36 89.30 19 A GLN 14 -58.58 105.61 19 A ARG 55 -104.26 -65.60 19 A GLU 76 -84.68 -76.58 19 A SER 78 -100.63 -68.10 19 A SER 79 176.65 -55.93 20 A ASN 10 -49.64 101.44 20 A GLN 14 -60.27 98.77 20 A THR 18 -142.45 -22.66 20 A GLU 20 -137.69 -63.77 20 A SER 87 -160.46 104.12 N De novo Designed Protein Foldit3 1 N N A GLU 20 A GLU 20 HELX_P A HIS 33 A HIS 33 1 AA1 14 A SER 58 A SER 58 HELX_P A GLU 76 A GLU 76 1 AA2 19 DE NOVO PROTEIN de no designed foldit foldit3, DE NOVO PROTEIN 6MSP PDB 1 1 6MSP 1 97 6MSP 1 97 6MSP A 1 1 97 4 anti-parallel anti-parallel anti-parallel A GLU 48 A GLU 48 A ARG 55 A ARG 55 A GLU 38 A GLU 38 A ILE 45 A ILE 45 A VAL 81 A VAL 81 A SER 87 A SER 87 A GLN 90 A GLN 90 A ASN 95 A ASN 95